Clinical Trials Directory

Trials / Completed

CompletedNCT00835523

Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist

OHSS Prevention by GnRH-agonist Triggering of Final Oocyte Maturation and Cryoperservation of All Two-pronucleate Oocytes in Women Undergoing Stimulation for IVF With Gonadotrophins and GnRH-analogues: a Prospective, Observational, Multicentric, Clinical Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
51 (actual)
Sponsor
University Hospital Schleswig-Holstein · Academic / Other
Sex
All
Age
18 Years – 39 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to explore the concept of GnRH-agonist triggering in combination with elective cryopreservation of all 2PN oocytes at larger scale in a pragmatic clinical setting. The question asked is: "Does GnRH-agonist triggering and cryopreservation work", in terms of efficacy and safety, when applied to a larger cohort of patients, and by a number of different centres with different clinical routines.

Conditions

Timeline

Start date
2008-05-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2009-02-03
Last updated
2012-06-14

Locations

10 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT00835523. Inclusion in this directory is not an endorsement.

Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist (NCT00835523) · Clinical Trials Directory